502 related articles for article (PubMed ID: 32739524)
1. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery.
Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Gupta U; Kesharwani P; Ravichandiran V; Kumar P; Naidu VGM; Murty US; Ajazuddin ; Alexander A
J Control Release; 2020 Nov; 327():235-265. PubMed ID: 32739524
[TBL] [Abstract][Full Text] [Related]
2. Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.
Singh RM; Kumar A; Pathak K
Expert Opin Drug Deliv; 2013 Jan; 10(1):115-30. PubMed ID: 23199072
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
4. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
[TBL] [Abstract][Full Text] [Related]
5. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin.
Mura P; Mennini N; Nativi C; Richichi B
Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194
[TBL] [Abstract][Full Text] [Related]
6. The prescription design and key properties of nasal gel for CNS drug delivery: A review.
Wang M; Ma X; Zong S; Su Y; Su R; Zhang H; Liu Y; Wang C; Li Y
Eur J Pharm Sci; 2024 Jan; 192():106623. PubMed ID: 37890640
[TBL] [Abstract][Full Text] [Related]
7. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
8. Formulation development and evaluation of nasal
Boraste SV; Patil SB
Drug Dev Ind Pharm; 2024 Jan; 50(1):11-22. PubMed ID: 38054848
[TBL] [Abstract][Full Text] [Related]
9. Smart Polymers in Nasal Drug Delivery.
Chonkar A; Nayak U; Udupa N
Indian J Pharm Sci; 2015; 77(4):367-75. PubMed ID: 26664051
[TBL] [Abstract][Full Text] [Related]
10. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
Galgatte UC; Kumbhar AB; Chaudhari PD
Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations.
Koo J; Lim C; Oh KT
Int J Nanomedicine; 2024; 19():1767-1807. PubMed ID: 38414526
[TBL] [Abstract][Full Text] [Related]
12. Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels.
Perez AP; Mundiña-Weilenmann C; Romero EL; Morilla MJ
Int J Nanomedicine; 2012; 7():1373-85. PubMed ID: 22457595
[TBL] [Abstract][Full Text] [Related]
13. Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson's disease.
Rao M; Agrawal DK; Shirsath C
Drug Dev Ind Pharm; 2017 Jan; 43(1):142-150. PubMed ID: 27533244
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Tamsulosin Hydrochloride-Loaded Mucoadhesive In Situ Gelling Polymeric Formulation for Nasal Delivery in Geriatrics.
Rana SJ; Zafar S; Shahzad A; Basit M; Mudassir J; Akhlaq M; Chohan TA; Arshad MS
AAPS PharmSciTech; 2023 Nov; 24(8):242. PubMed ID: 38017208
[TBL] [Abstract][Full Text] [Related]
15. Development and Evaluation of pH-Responsive Cyclodextrin-Based in situ Gel of Paliperidone for Intranasal Delivery.
Sherje AP; Londhe V
AAPS PharmSciTech; 2018 Jan; 19(1):384-394. PubMed ID: 28748368
[TBL] [Abstract][Full Text] [Related]
16. Piribedil loaded thermo-responsive nasal in situ gelling system for enhanced delivery to the brain: formulation optimization, physical characterization, and in vitro and in vivo evaluation.
Uppuluri CT; Ravi PR; Dalvi AV; Shaikh SS; Kale SR
Drug Deliv Transl Res; 2021 Jun; 11(3):909-926. PubMed ID: 32514705
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery to the brain: In situ gelling formulation enhances carbamazepine diffusion through nasal mucosa models with mucin.
Corazza E; di Cagno MP; Bauer-Brandl A; Abruzzo A; Cerchiara T; Bigucci F; Luppi B
Eur J Pharm Sci; 2022 Dec; 179():106294. PubMed ID: 36116696
[TBL] [Abstract][Full Text] [Related]
18. In situ gel-forming system: an attractive alternative for nasal drug delivery.
Wang X; Liu G; Ma J; Guo S; Gao L; Jia Y; Li X; Zhang Q
Crit Rev Ther Drug Carrier Syst; 2013; 30(5):411-34. PubMed ID: 24099327
[TBL] [Abstract][Full Text] [Related]
19. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
[TBL] [Abstract][Full Text] [Related]
20. Patient-Friendly, Olfactory-Targeted, Stimuli-Responsive Hydrogels for Cerebral Degenerative Disorders Ensured > 400% Brain Targeting Efficiency in Rats.
Nafee N; Ameen AER; Abdallah OY
AAPS PharmSciTech; 2020 Nov; 22(1):6. PubMed ID: 33222021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
